Your browser doesn't support javascript.
loading
Phase I study of liposomal irinotecan (LY01610) in patients with advanced esophageal squamous cell carcinoma.
Liu, Yun; Zhang, Bo; Xu, Jianping; Wang, Xingyuan; Tang, Jialin; Huang, Jing.
Afiliação
  • Liu Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang, 100021, Beijing, China.
  • Zhang B; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang, 100021, Beijing, China.
  • Xu J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang, 100021, Beijing, China. 13651379626@139.com.
  • Wang X; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang, 100021, Beijing, China.
  • Tang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang, 100021, Beijing, China.
  • Huang J; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang, 100021, Beijing, China. huangjingwg@163.com.
Cancer Chemother Pharmacol ; 88(3): 403-414, 2021 09.
Article em En | MEDLINE | ID: mdl-34031756

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Inibidores da Topoisomerase I / Irinotecano / Carcinoma de Células Escamosas do Esôfago Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Inibidores da Topoisomerase I / Irinotecano / Carcinoma de Células Escamosas do Esôfago Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Alemanha